|
|
|
Volumn 58, Issue 5, 2008, Pages 541-544
|
|
Treatment of systemic vasculitides;Traitement des vascularites systémiques
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CORTICOSTEROID;
ETANERCEPT;
INFLIXIMAB;
RECOMBINANT INTERFERON;
RIBAVIRIN;
RITUXIMAB;
ANTIVIRAL THERAPY;
DISEASE ASSOCIATION;
DISEASE SEVERITY;
IMMUNOSUPPRESSIVE TREATMENT;
NECROTIZING ARTERITIS;
PROGNOSIS;
SCORING SYSTEM;
SHORT SURVEY;
SYSTEMIC VASCULITIS;
TREATMENT DURATION;
TREATMENT OUTCOME;
VIRUS INFECTION;
ADRENAL CORTEX HORMONES;
ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL;
ANTIVIRAL AGENTS;
AZATHIOPRINE;
CHURG-STRAUSS SYNDROME;
CLINICAL TRIALS AS TOPIC;
CRYOGLOBULINEMIA;
CYCLOPHOSPHAMIDE;
DRUG THERAPY, COMBINATION;
HEPATITIS B;
HUMANS;
IMMUNOGLOBULIN G;
IMMUNOGLOBULINS, INTRAVENOUS;
IMMUNOSUPPRESSIVE AGENTS;
INTERFERONS;
PLASMA EXCHANGE;
POLYARTERITIS NODOSA;
PROGNOSIS;
PROSPECTIVE STUDIES;
RECEPTORS, TUMOR NECROSIS FACTOR;
RECURRENCE;
RIBAVIRIN;
RISK;
SEVERITY OF ILLNESS INDEX;
TIME FACTORS;
TUMOR NECROSIS FACTOR-ALPHA;
VASCULITIS;
VIRUS DISEASES;
WEGENER GRANULOMATOSIS;
|
|
EID: 41449116560
PISSN: 00352640
EISSN: None
Source Type: Journal
DOI: None Document Type: Short Survey |
|
Times cited : (2)
|
|
References (7)
|
